Security key
87184Q107
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)
CUSIP: 87184Q107
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 60,879,549
- Total 13F value
- $453,765,087
- Share change
- +7,225,913
- Put/Call ratio
- 179%
- SEC-reported price per share
- $7.48
- Number of holders
- 99
- Value change
- +$51,303,227
- Number of buys
- 57
- Number of sells
- 40
- Shares outstanding
- 27,995,500
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
99
Top holders
10
SYRS full security history
Ownership snapshot
Full 13F holder table
Syros Pharmaceuticals, Inc. SEC filings
Syros Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 32%
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 32%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
32%
FMR LLC
24%
Bain Capital Life Sciences Invest...
21%
Amova Asset Management Americas, ...
16%
Sumitomo Mitsui Trust Group, Inc.
16%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
Company
|
32%
|
$98,098,000
9,041,321 shares
|
— | 31 Dec 2020 |
| FMR LLC |
13F
Company
|
24%
|
$72,053,000
6,640,835 shares
|
— | 31 Dec 2020 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
21%
|
$62,768,000
5,785,036 shares
|
— | 31 Dec 2020 |
| Amova Asset Management Americas, Inc. |
13F
Company
|
16%
|
$47,545,000
4,381,992 shares
|
— | 31 Dec 2020 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
Company
|
16%
|
$47,545,000
4,381,992 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
12%
|
$36,082,000
3,325,560 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
99
Shares
60,879,549
Rows available
99
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2021 Across Filers
Q1 2021 holders
99
Q1 2021 holders
99
Holder diff
0
| Investor | Q1 2021 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q1 2021 value | Value change | Value Chg % |
|---|